Stanford University


Showing 5,601-5,610 of 7,825 Results

  • Marlene Rabinovitch

    Marlene Rabinovitch

    Dwight and Vera Dunlevie Professor of Pediatric Cardiology

    Current Research and Scholarly InterestsOur research program seeks to identify the cellular and molecular programs regulating vascular and lung development, through the use of cultured cells and tissues and mouse and rat models. We then determine how these programs are perturbed by genetic abnormalities or injurious processes associated with disease, focusing on pulmonary arterial hypertension (PAH), a fatal complication in children with heart defects, and a condition of unknown etiology primarily in young women.

  • Ralph Rabkin

    Ralph Rabkin

    Professor of Medicine, Emeritus

    Current Research and Scholarly InterestsDr Rabkin is examining the mechanism of the acquired resistance to hormones that develops in kidney failure.In particular he is studying the impact of kidney failure on the action of growth hormone and the role of impaired signal transduction as a cause of growth hormone resistance. He is also engaged in the study of growth factors in diabetic kidney disease.

  • Jillian Rafferty

    Jillian Rafferty

    CSA & Lecturer in Law, Internatl Human Rights & Conflict Resolution Clinic

    Current Research and Scholarly InterestsRafferty’s work has focused on the human rights of marginalized groups, discrimination, armed conflict and other humanitarian emergencies, counter-terrorism, and humanitarian disarmament. Her academic research interests include the co-application of international human rights law and international humanitarian law, the protection of economic, social, and cultural rights during armed conflict, and both gender- and disability-based violence and discrimination.

  • Thomas Raffin

    Thomas Raffin

    The Colleen and Robert Haas Professor in Medicine and Biomedical Ethics, Emeritus

    Current Research and Scholarly InterestsDr. Raffin is a clinician, teacher and investigator. He retired as Chief of the Division of Pulmonary and Critical Care Medicine in 2004. His key areas of academic interest include the biology and management of acute lung injury; basic biology of human lung and white cells; and, key issues in biomedical ethics including withholding and withdrawing life support, health care delivery, genomics, genetic screening, and neuroethics.

  • Nilima Ragavan

    Nilima Ragavan

    Clinical Professor, Pediatrics - Neonatology

    BioDr Nilima Ragavan is a Neonatologist and Clinical Professor at the Stanford University School of Medicine. She is an experienced clinician who has expertise in the care of critically ill newborns.She is the Neonatal Outreach Medical director for Stanford Children's health, Co director of the Mid Coastal California Perinatal Outreach Program, and the Medical director of the Special care Nursery at Stanford Children's Health.She serves as a mentor to junior faculty. Dr Ragavan is passionate about education, and social justice. She has worked in and promoted social organizations in the fields of education, health care, livelihood and women's empowerment in India.She founded a group called Teach to Heal to promote cross cultural education and has led several multidisciplinary medical teams to India, as well as organized and conducted international neonatal and perinatal conferences.

  • Srinivas Raghu

    Srinivas Raghu

    Professor of Physics

    BioI am interested in the emergent behavior of quantum condensed matter systems. Some recent research topics include non-Fermi liquids, quantum criticality, statistical mechanics of strongly interacting and disordered quantum systems, physics of the half-filled Landau level, quantum Hall to insulator transitions, superconductor-metal-insulator transitions, and the phenomenology of quantum materials.

    Past contributions that I'm particularly proud of include the co-founding of the subject of topological photonics (with Duncan Haldane), scaling theories of non-Fermi liquid metals (with Shamit Kachru and Gonzalo Torroba), Euclidean lattice descriptions of Chern-Simons matter theories and their dualities in 2+1 dimensions (with Jing-Yuan Chen and Jun Ho Son), and 'dual' perspectives of quantum Hall transitions (with Prashant Kumar and Michael Mulligan).

  • Amer Raheemullah

    Amer Raheemullah

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioDr. Amer Raheemullah, MD, is Associate Clinical Professor of Psychiatry and Behavioral Sciences at Stanford University. He is the Director of Stanford Hospital Addiction Services (shas.stanford.edu), which he initially launched at a single site, and after demonstrating significant improvements in patient outcomes, led its expansion across Stanford’s multiple hospital sites.

    His research and insights on habits and addictive behavior have been published in leading journals including JAMA and Cambridge University Press, and has been featured in media outlets such as Bloomberg News, ABC7 News, KQED, and Everyday Health. He has been invited to advise on national addiction policy by the U.S. Food and Drug Administration (FDA), the U.S. Department of Health and Human Services (HHS), the Substance Abuse and Mental Health Services Administration (SAMHSA), as well as the Congress-established Reagan-Udall Foundation. He has also consulted for several Silicon Valley digital health startups focused on habits and addictive behaviors, such as Lucid Lane, where he led the development and expansion of clinical programs that enabled the organization to grow from a single-state initiative into a nationally operating program within a few years.

    His academic work focuses on translating research into scalable models of addiction treatment that can be integrated into health care systems, digital health interventions, and public policy to expand access to high-quality, evidence-based care. Since completing his addiction medicine training at Stanford University School of Medicine, he has continued to work directly with patients across a wide range of settings, including community-based programs, sober living environments, outpatient clinics, residential treatment facilities, inpatient units, and correctional settings.